Skip to main content
Top
Published in: Lasers in Medical Science 7/2019

Open Access 01-09-2019 | CO2 Laser | Original Article

Voice improvement in patients with recurrent respiratory papillomatosis after combined treatment with cidofovir and CO2 laser surgery

Authors: Joanna Jackowska, Waldemar Wojnowski, Anna Hashimoto, Bogna Małaczyńska, Krzysztof Piersiala, Piotr Świdziński, Bożena Wiskirska-Woźnica, Małgorzata Wierzbicka

Published in: Lasers in Medical Science | Issue 7/2019

Login to get access

Abstract

Mechanical debulking of laryngeal papillomas is associated with voice disorders due to impairment of the vocal fold’s mucosa. Intraepithelial injection of cidofovir reduces damage to the laryngeal structures and thus improves vocal parameters. The aim of our study was to compare vocal quality before and after cidofovir and CO2 laser treatment by means of objective phoniatric parameters and to obtain evidence concerning voice outcomes. The vocal parameters of 42 patients with RRP were assessed before and after intralesional cidofovir and CO2 laser debulking treatment (Lumenis AcuPulse 40 CO2 laser, wavelength 10.6 μm; Lumenis Ltd., Yokneam, Israel). The laser was used in SuperPulse mode with power tailored on the target structures (average 7 W). The depth of tissue penetration was 1 mm with a single burst of energy lasting 0.3 ms. Most of the patients had previously undergone traditional surgery (1–105 procedures); in 7/42, the video stroboscopic examination revealed extensive scar tissue covering the mucosa of the vocal folds, limiting the mucosal wave. The significance level for all calculations was p < 0.05. Statistical analysis was performed using Statistica 10 by StatSoft Polska. The methodology included subjective voice evaluation (GRBAS), videostroboscopy, analysis of the acoustic laryngeal tone (MDVP), spectrographic analysis, and voice handicap index (VHI). The GRBAS scale during spontaneous conversation revealed better phonation results after cidofovir treatment in all 42 patients. Scars were not observed in the presented group. In the MDVP laryngeal tone analysis before surgery parameters defining the amplitude and frequency of laryngeal tone were significantly elevated compared to the state after surgery. After treatment, both jitter and shimmer were reduced in all subjects. Even more pronounced changes were observed in the spectrographic analysis. In all analyzed patients, there was a significant reduction in VHI scores showing improvement in voice self-assessment. A satisfactory improvement in voice quality was observed in all RRP patients treated with cidofovir and CO2 laser.
Literature
1.
go back to reference Stamataki S, Nikolopoulos TP, Korres S, Felekis D, Tzangaroulakis A, Ferekidis E (2007) Juvenile recurrent respiratory papillomatosis: still a mystery disease with difficult management. Head Neck 29:155–162CrossRefPubMed Stamataki S, Nikolopoulos TP, Korres S, Felekis D, Tzangaroulakis A, Ferekidis E (2007) Juvenile recurrent respiratory papillomatosis: still a mystery disease with difficult management. Head Neck 29:155–162CrossRefPubMed
2.
go back to reference Larson DA, Derkay CS (2010) Epidemiology of recurrent respiratory papillomatosis. APMIS 118:450–454CrossRefPubMed Larson DA, Derkay CS (2010) Epidemiology of recurrent respiratory papillomatosis. APMIS 118:450–454CrossRefPubMed
3.
go back to reference Holler T, Allegro J, Chadha NK, Hawkes M, Harrison RV, Forte V, Campisi P (2009) Voice outcomes following repeated surgical resection of laryngeal papillomata in children. Otolaryngol Head Neck Surg 141:522–526CrossRefPubMed Holler T, Allegro J, Chadha NK, Hawkes M, Harrison RV, Forte V, Campisi P (2009) Voice outcomes following repeated surgical resection of laryngeal papillomata in children. Otolaryngol Head Neck Surg 141:522–526CrossRefPubMed
4.
go back to reference Snoeck R, Wellens W, Desloovere C, Van Ranst M, Naesens L, De Clercq E, Feenstra L (1998) Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]. J Med Virol 54:219–225CrossRefPubMed Snoeck R, Wellens W, Desloovere C, Van Ranst M, Naesens L, De Clercq E, Feenstra L (1998) Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]. J Med Virol 54:219–225CrossRefPubMed
5.
go back to reference Wierzbicka M, Jackowska J, Bartochowska A, Józefiak A, Szyfter W, Kędzia W (2011) Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol 268:1305–1311CrossRefPubMedPubMedCentral Wierzbicka M, Jackowska J, Bartochowska A, Józefiak A, Szyfter W, Kędzia W (2011) Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol 268:1305–1311CrossRefPubMedPubMedCentral
6.
go back to reference Dikkers FG (2006) Treatment of recurrent respiratory papillomatosis with microsurgery in combination with intralesional cidofovir—a prospective study. Eur Arch Otorhinolaryngol 263:440–443CrossRefPubMed Dikkers FG (2006) Treatment of recurrent respiratory papillomatosis with microsurgery in combination with intralesional cidofovir—a prospective study. Eur Arch Otorhinolaryngol 263:440–443CrossRefPubMed
7.
go back to reference Pudszuhn A, Welzel C, Bloching M, Neumann K (2007) Intralesional Cidofovir application in recurrent laryngeal papillomatosis. Eur Arch Otorhinolaryngol 264:63–70CrossRefPubMed Pudszuhn A, Welzel C, Bloching M, Neumann K (2007) Intralesional Cidofovir application in recurrent laryngeal papillomatosis. Eur Arch Otorhinolaryngol 264:63–70CrossRefPubMed
8.
go back to reference Jacobson BH, Johnson A, Grywalski C, Silbergleit A, Jacobson G, Benninger MS, Newman CW (1997) The voice handicap index (VHI): development and validation. Am J Speech-Language Pathol 6:66–70CrossRef Jacobson BH, Johnson A, Grywalski C, Silbergleit A, Jacobson G, Benninger MS, Newman CW (1997) The voice handicap index (VHI): development and validation. Am J Speech-Language Pathol 6:66–70CrossRef
9.
go back to reference Hakkesteegt MM, Brocaar MP, Wieringa MH (2010) The applicability of the dysphonia severity index and the voice handicap index in evaluating effects of voice therapy and phonosurgery. J Voice 24:199–205CrossRefPubMed Hakkesteegt MM, Brocaar MP, Wieringa MH (2010) The applicability of the dysphonia severity index and the voice handicap index in evaluating effects of voice therapy and phonosurgery. J Voice 24:199–205CrossRefPubMed
10.
go back to reference De Bodt MS, Wuyts FL, Van de Heyning PH, Croux C (1997) Test-retest study of the GRBAS scale: influence of experience and professional background on perceptual rating of voice quality. J Voice 11:74–80CrossRef De Bodt MS, Wuyts FL, Van de Heyning PH, Croux C (1997) Test-retest study of the GRBAS scale: influence of experience and professional background on perceptual rating of voice quality. J Voice 11:74–80CrossRef
11.
go back to reference Mikolajczak S, Quante G, Weissenborn S, Wafaisade A, Wieland U, Lüers JC, Klussmann JP, Beutner D (2012) The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol 269:2543–2548CrossRefPubMed Mikolajczak S, Quante G, Weissenborn S, Wafaisade A, Wieland U, Lüers JC, Klussmann JP, Beutner D (2012) The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol 269:2543–2548CrossRefPubMed
12.
go back to reference Tjon Pian Gi RE, Ilmarinen T, van den Heuvel ER, Aaltonen LM, Andersen J et al (2013) Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients. Eur Arch Otorhinolaryngol 270:1679–1687CrossRefPubMed Tjon Pian Gi RE, Ilmarinen T, van den Heuvel ER, Aaltonen LM, Andersen J et al (2013) Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients. Eur Arch Otorhinolaryngol 270:1679–1687CrossRefPubMed
13.
go back to reference Derkay CS, Volsky PG, Rosen CA, Pransky SM, McMurray JS, Chadha NK, Froehlich P (2013) Current use of intralesional cidofovir for recurrent respiratory papillomatosis. Laryngoscope 123:705–712CrossRefPubMed Derkay CS, Volsky PG, Rosen CA, Pransky SM, McMurray JS, Chadha NK, Froehlich P (2013) Current use of intralesional cidofovir for recurrent respiratory papillomatosis. Laryngoscope 123:705–712CrossRefPubMed
14.
go back to reference Stewart MG, Chen AY, Stach CB (1998) Outcomes analysis of voice and quality of life in patients with laryngeal cancer. Arch Otolaryngol Head Neck Surg 124:143–148CrossRefPubMed Stewart MG, Chen AY, Stach CB (1998) Outcomes analysis of voice and quality of life in patients with laryngeal cancer. Arch Otolaryngol Head Neck Surg 124:143–148CrossRefPubMed
15.
go back to reference Wiskirska-Woźnica B, Leszczyńska M, Swidziński, Czerniejewska H, Jackowska J, Witold S (2011) Voice estimation in patients after reconstructive subtotal laryngectomy. Head Neck Oncol 3:46PubMedPubMedCentral Wiskirska-Woźnica B, Leszczyńska M, Swidziński, Czerniejewska H, Jackowska J, Witold S (2011) Voice estimation in patients after reconstructive subtotal laryngectomy. Head Neck Oncol 3:46PubMedPubMedCentral
16.
go back to reference Lindman JP, Gibbons MD, Morlier R, Wiatrak BJ (2004) Voice quality of prepubescent children with quiescent recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 68:529–536CrossRefPubMed Lindman JP, Gibbons MD, Morlier R, Wiatrak BJ (2004) Voice quality of prepubescent children with quiescent recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 68:529–536CrossRefPubMed
17.
go back to reference Lehto L, Aaltonen LM, Rihkanen H (2007) Longstanding recurrent laryngeal papillomatosis: impact on voice quality. Eur Arch Otorhinolaryngol 264:777–782CrossRefPubMed Lehto L, Aaltonen LM, Rihkanen H (2007) Longstanding recurrent laryngeal papillomatosis: impact on voice quality. Eur Arch Otorhinolaryngol 264:777–782CrossRefPubMed
18.
go back to reference Chan RW, Gray SD, Titze IR (2001) The importance of hyaluronic acid in vocal fold biomechanics. Otolaryngol Head Neck Surg 124:607–614CrossRefPubMed Chan RW, Gray SD, Titze IR (2001) The importance of hyaluronic acid in vocal fold biomechanics. Otolaryngol Head Neck Surg 124:607–614CrossRefPubMed
19.
go back to reference Kashima H, Mounts P, Leventhal B, Hruban RH (1993) Sites of predilection in recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 102:580–583CrossRefPubMed Kashima H, Mounts P, Leventhal B, Hruban RH (1993) Sites of predilection in recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 102:580–583CrossRefPubMed
Metadata
Title
Voice improvement in patients with recurrent respiratory papillomatosis after combined treatment with cidofovir and CO2 laser surgery
Authors
Joanna Jackowska
Waldemar Wojnowski
Anna Hashimoto
Bogna Małaczyńska
Krzysztof Piersiala
Piotr Świdziński
Bożena Wiskirska-Woźnica
Małgorzata Wierzbicka
Publication date
01-09-2019
Publisher
Springer London
Keyword
CO2 Laser
Published in
Lasers in Medical Science / Issue 7/2019
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI
https://doi.org/10.1007/s10103-019-02735-2

Other articles of this Issue 7/2019

Lasers in Medical Science 7/2019 Go to the issue